Are you Dr. Nolen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5808 W 110th St
Overland Park, KS 66211Phone+1 913-696-8000Fax+1 816-302-9939
Summary
- Dr. John Nolen, MD is a board certified pathologist in Overland Park, Kansas. He is currently licensed to practice medicine in Kansas, Missouri, and Alabama. He is affiliated with Children's Mercy Kansas City.
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Blood Banking/Transfusion Medicine, 2005 - 2006
- Emory University School of MedicineResidency, Pathology-Anatomic and Clinical, 2001 - 2005
- Tulane University School of MedicineClass of 2001
Certifications & Licensure
- KS State Medical License 2017 - 2025
- MO State Medical License 2017 - 2025
- GA State Medical License 2003 - 2017
- FL State Medical License 2007 - 2010
- AL State Medical License 2007 - 2008
- PA State Medical License 2006 - 2008
- IA State Medical License 2005 - 2007
- American Board of Pathology Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
- American Board of Pathology Clinical Informatics
Publications & Presentations
PubMed
- 43 citationsProteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers.Fatima W. Khwaja, John D. L. Nolen, Savaas E. Mendrinos, Melinda M. Lewis, Jeffrey J. Olson
Proteomics. 2006-12-01 - 19 citationsMuscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1)Khaled M Badr, John D. L. Nolen, Patricia B. DeRose, Cynthia Cohen
Human Pathology. 2004-02-01 - 11 citationsp53, cellular proliferation, and apoptosis-related factors in thymic neuroendocrine tumorsAnthony A. Gal, Mary N. Sheppard, John D. L. Nolen, Cynthia Cohen
Modern Pathology. 2004-01-01